The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Mekori, Y. A.
Right arrow Articles by Metcalfe, D. D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Mekori, Y. A.
Right arrow Articles by Metcalfe, D. D.

The Journal of Immunology, Vol 153, Issue 5 2194-2203, Copyright © 1994 by American Association of Immunologists


ARTICLES

Transforming growth factor-beta prevents stem cell factor-mediated rescue of mast cells from apoptosis after IL-3 deprivation

YA Mekori and DD Metcalfe
Department of Medicine, Meir Hospital Kfar-Saba, Tel-Aviv University, Israel.

IL-3-dependent mast cells undergo apoptosis upon removal of IL-3, an event that is prevented by the addition of stem cell factor (SCF) acting through its receptor c-kit, suggesting that SCF provides a mechanism to allow mast cells to survive and to differentiate in tissues in the relative absence of IL-3. This observation is consistent with the thesis that the microenvironment, in part, controls mast cell number and viability by modulating SCF production and release. The purpose of the present study was to determine whether a second factor, TGF-beta 1, was capable of modifying the SCF-mediated survival pathway. TGF-beta 1 (1 and 10 ng/ml), known to be an important regulator of cell growth and function, did inhibit the SCF-mediated rescue from apoptosis in IL-3-deprived mast cells. TGF-beta 1 exerted its inhibitory effect on SCF-mediated rescue from apoptosis, even when added 4 h after the addition of SCF. In contrast, TGF-beta 1 had no substantial effect on the viability of mast cells that were grown in the presence of IL-3. TGF-beta 1 also had no noticeable effect on viability and proliferation of a growth factor-independent mast cell line. The inhibitory effect of TGF-beta 1 was neutralized by specific anti-TGF-beta mAb. TGF-beta 1 did not affect the expression of c-kit, as determined by using flow cytometric analysis of mast cells labeled with FITC-conjugated anti-c- kit. These results demonstrate how SCF and TGF-beta may act in concert to regulate mast cell numbers under physiologic or pathologic conditions.


This article has been cited by other articles:


Home page
GutHome page
T Gebhardt, A Lorentz, F Detmer, C Trautwein, H Bektas, M P Manns, and S C Bischoff
Growth, phenotype, and function of human intestinal mast cells are tightly regulated by transforming growth factor {beta}1
Gut, July 1, 2005; 54(7): 928 - 934.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
G. Gomez, C. D. Ramirez, J. Rivera, M. Patel, F. Norozian, H. V. Wright, M. V. Kashyap, B. O. Barnstein, K. Fischer-Stenger, L. B. Schwartz, et al.
TGF-{beta}1 Inhibits Mast Cell Fc{epsilon}RI Expression
J. Immunol., May 15, 2005; 174(10): 5987 - 5993.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
M. F. Gurish, P. J. Bryce, H. Tao, A. B. Kisselgof, E. M. Thornton, H. R. Miller, D. S. Friend, and H. C. Oettgen
IgE Enhances Parasite Clearance and Regulates Mast Cell Responses in Mice Infected with Trichinella spiralis
J. Immunol., January 15, 2004; 172(2): 1139 - 1145.
[Abstract] [Full Text] [PDF]


Home page
J. Exp. Med.Home page
M. F. Gurish, H. Tao, J. P. Abonia, A. Arya, D. S. Friend, C. M. Parker, and K. F. Austen
Intestinal Mast Cell Progenitors Require CD49d{beta}7 ({alpha}4{beta}7 Integrin) for Tissue-specific Homing
J. Exp. Med., October 29, 2001; 194(9): 1243 - 1252.
[Abstract] [Full Text] [PDF]


Home page
Ann Rheum DisHome page
N Olsson, A-K Ulfgren, and G Nilsson
Demonstration of mast cell chemotactic activity in synovial fluid from rheumatoid patients
Ann Rheum Dis, March 1, 2001; 60(3): 187 - 193.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Cell Mol. Bio.Home page
R. O. Sanchez Mejia, B. K. Lam, and J. P. Arm
Matrix-Associated Transforming Growth Factor-beta 1 Primes Mouse Bone Marrow-Derived Mast Cells for Increased High-Affinity Fc Receptor for Immunoglobulin E-Dependent Eicosanoid Biosynthesis
Am. J. Respir. Cell Mol. Biol., May 1, 2000; 22(5): 557 - 565.
[Abstract] [Full Text]


Home page
BloodHome page
H. R.P. Miller, S. H. Wright, P. A. Knight, and E. M. Thornton
A Novel Function for Transforming Growth Factor-{beta}1: Upregulation of the Expression and the IgE-Independent Extracellular Release of a Mucosal Mast Cell Granule-Specific {beta}-Chymase, Mouse Mast Cell Protease-1
Blood, May 15, 1999; 93(10): 3473 - 3486.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
K. C. Fang, P. J. Wolters, M. Steinhoff, A. Bidgol, J. L. Blount, and G. H. Caughey
Mast Cell Expression of Gelatinases A and B Is Regulated by kit Ligand and TGF-{beta}
J. Immunol., May 1, 1999; 162(9): 5528 - 5535.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 1994 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 1994 by The American Association of Immunologists, Inc. All rights reserved.